Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is N/A as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
N/A
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
0.00%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Eloxx Pharmaceuticals, Inc.
Market Cap
$51.99M
Net Profit Margin
N/A
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$51.88M
Net Profit Margin
-5668.62%
TTM Avg
-3356.71%
3Y Avg
-1974.47%
5Y Avg
-1414.89%
Market Cap
$52.60M
Net Profit Margin
-59.97%
TTM Avg
-26.95%
3Y Avg
-5.27%
5Y Avg
-0.58%
Market Cap
$51.19M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$52.83M
Net Profit Margin
-69.27%
TTM Avg
-45.15%
3Y Avg
-54.32%
5Y Avg
-40.58%
Market Cap
$51.12M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$53.70M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eloxx Pharmaceuticals, Inc. (ELOX) | $51.99M | N/A | 0.00% | 0.00% | 0.00% |
| ImageneBio Inc (IMA)vs › | $51.88M | -5668.62% | -3356.71% | -1974.47% | -1414.89% |
| Zhengye Biotechnology Holding Limited (ZYBT)vs › | $52.60M | -59.97% | -26.95% | -5.27% | -0.58% |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | 0.00% | 0.00% | 0.00% | 0.00% |
| Tenax Therapeutics, Inc. (TENX)vs › | $51.19M | 0.00% | 0.00% | 0.00% | 0.00% |
| Spectral AI, Inc. (MDAI)vs › | $52.83M | -69.27% | -45.15% | -54.32% | -40.58% |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $51.12M | 0.00% | 0.00% | 0.00% | 0.00% |
| biote Corp. (BTMD)vs › | $50.28M | 3.19% | 7.83% | 4.22% | 10.88% |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $53.70M | 0.00% | 0.00% | 0.00% | 0.00% |
| Envoy Medical, Inc. (COCH)vs › | $50.27M | -11304.83% | -9549.74% | -8821.76% | -6347.57% |
Operating Margin
N/A
Net Profit Margin
N/A
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-03-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | -10281.12% |
| 2015-09-30 | -481.98% |
